SVP Inhalational Pharmacology & Toxicology
Dr Jeffrey Tepper PhD DABT brings than 35 years’ experience in inhalational drug development to Rage. Jeff is Board certified in toxicology and safety pharmacology and has shepherded many early drug concepts from animal pharmacology through GLP toxicology and into clinical studies.
Dr Tepper honed his skills as a Senior Scientist at Genentech, Director of Pharmacology at Bayer Biotechnology, VP of Pharmacology/Toxicology at Catalyst Biosciences and as a Co-Founder and Senior Director Pharmacology/Toxicology of Aerovance Inc., a respiratory-focused biotech company.
Jeff specialises in nonclinical drug development, inhalation toxicology and respiratory pharmacology, with experience in multiple indications: inflammatory, cardiovascular, gastrointestinal, ophthalmology and arthropathy; delivery routes: inhalation, intranasal, intra-articular and intravitreal; and therapeutic platforms: recombinant and engineered proteins, oligonucleotides, antibodies, peptides, small molecules, PEGylated molecules and drug-device combinations.